| Identification | Back Directory | [Name]
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile | [CAS]
1187594-13-3 | [Synonyms]
Barretinib intermediate 2 2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile (trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile 2-[1-ethanesulfonyl-3-[4-(7-[(2-(trimethylsilyl)ethoxy)methyl]-7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-yl]azetidin-3-yl]acetonitrile 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile 2-[1-ethanesulfonyl-3-[4-(7-[(2-(trimethylsilyl)ethoxy)methyl]-7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl]acetonitrile | [Molecular Formula]
C22H31N7O3SSi | [MDL Number]
MFCD33551930 | [MOL File]
1187594-13-3.mol | [Molecular Weight]
501.68 |
| Chemical Properties | Back Directory | [Boiling point ]
696.8±65.0 °C(Predicted) | [density ]
1.30±0.1 g/cm3(Predicted) | [pka]
3.70±0.30(Predicted) | [InChIKey]
WUWJJJDMZWZKQS-UHFFFAOYSA-N | [SMILES]
N1(S(CC)(=O)=O)CC(N2C=C(C3N=CN=C4N(COCC[Si](C)(C)C)C=CC4=3)C=N2)(CC#N)C1 |
| Hazard Information | Back Directory | [Uses]
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile is a reference standard for the impurity of Baricitinib, used for the registration and quality control of related drugs. |
|
| Company Name: |
Twochem Co.Ltd.
|
| Telephone: |
021-58111628 15800915896 |
| Website: |
cn.twochem.com |
| Company Name: |
TOSUN PHARM
|
| Telephone: |
020-66392521-118 18922260391 |
| Website: |
www.toref.cn/ |
| Company Name: |
Shanghai UCHEM Inc.
|
| Telephone: |
+86-18930848214 +86-021-56762820 |
| Website: |
http://www.myuchem.com/ |
|